Literature DB >> 30819659

Predictors and outcomes of disseminated tuberculosis in an intermediate burden setting.

L Meira1, C Chaves2, D Araújo1, L Almeida1, R Boaventura1, A Ramos3, T Carvalho3, N S Osório2, A G Castro2, F Rodrigues2, J T Guimarães4, M Saraiva5, H N Bastos6.   

Abstract

SETTING: University-affiliated hospital located in Porto, North Portugal, an area with a low to intermediate incidence of tuberculosis (TB).
OBJECTIVE: To identify predictors and outcomes of disseminated TB (dTB).
DESIGN: A cohort of patients diagnosed with TB between 2007 and 2013 was retrospectively analysed. Patients with dTB criteria were characterized and compared to single organ TB cases. Factors independently associated with dTB were determined by multivariate logistic regression analysis.
RESULTS: A total of 744 patients were analysed, including 145 with dTB. Independent risk factors for dTB were pharmacological immunosuppression (OR 5.6, 95% CI 2.8-11.3), HIV infection (OR 5.1, 95% CI 3.1-8.3), chronic liver failure or cirrhosis (OR 2.3, 95% CI 1.4-4.1) and duration of symptoms (OR 2.3, 95% CI 1.4-3.8). Compared to single organ TB, the clinical presentation of dTB patients differed by the absence of haemoptysis (OR 3.2, 95% CI 1.3-8.4) and of dyspnoea (OR 1.9, 95% CI 1.2-3.1), presence of weight loss (OR 1.8, 95% CI 1.1-2.9), night sweats (OR 1.7, 95% CI 1.1-2.7) and bilateral lung involvement (OR 4.4, 95% CI 2.8-7.1). Mortality and time until culture conversion were higher for dTB patients, although not reaching statistical significance.
CONCLUSION: Immunosuppressive conditions and chronic liver failure or cirrhosis were associated with increased risk of dTB. The haematogenous spread may be dependent on longer symptomatic disease and usually progresses with bilateral lung involvement.
Copyright © 2018 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Disseminated tuberculosis; Mycobacterium tuberculosis; Outcome; Risk factors

Mesh:

Substances:

Year:  2019        PMID: 30819659     DOI: 10.1016/j.pulmoe.2018.11.001

Source DB:  PubMed          Journal:  Pulmonology        ISSN: 2531-0429


  4 in total

1.  The prevalence of concurrent pulmonary and extrapulmonary tuberculosis in Uganda: a retrospective study.

Authors:  Eddy Kyagulanyi; Joy Mirembe; Brandy Nantaayi; Sonita Nalukenge; David Mukasa; Jaffar Tamale; Anthony Oriekot; Moses R Kamya; Joseph Baruch Baluku
Journal:  Ther Adv Infect Dis       Date:  2022-06-30

2.  Disseminated Tuberculosis: A 3-Year Case-Series Experience in a Tertiary Care Center.

Authors:  Canan Gunduz Gurkan; Hamide Şekerbey; Aylin Babalık
Journal:  Turk Thorac J       Date:  2021-09

3.  A Case Report of Widely Disseminated Tuberculosis in Immunocompetent Adult Male.

Authors:  Samantha B Esposito; Joseph Levi; Zachary M Matuzsan; Alexandra M Amaducci; David M Richardson
Journal:  Clin Pract Cases Emerg Med       Date:  2020-08

4.  Association of Tumor Necrosis Factor α Inhibitor Use with Diagnostic Features and Mortality of Tuberculosis in the United States, 2010-2017.

Authors:  Shereen S Katrak; Rongxia Li; Sue Reynolds; Suzanne M Marks; Jessica R Probst; Terence Chorba; Kevin Winthrop; Kenneth G Castro; Neela D Goswami
Journal:  Open Forum Infect Dis       Date:  2021-12-22       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.